Sucampo Pharmaceuticals, Inc. 5
5 · Sucampo Pharmaceuticals, Inc. · Filed Feb 16, 2016
Insider Transaction Report
Form 5
Ueno Ryuji
DirectorCEO, Chief Scientific Officer10% Owner
Transactions
- Gift
Class A Common Stock
2015-08-27−2,000,000→ 18,274,689 total(indirect: By LLC)
Footnotes (1)
- [F1]S&R Technology Holdings, LLC is wholly owned by Dr. Ueno and his wife. Dr. Ueno disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.